TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
Titel:
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
Auteur:
Eckardt, Julia Schroeder, Christopher Martus, Peter Armeanu-Ebinger, Sorin Kelemen, Olga Gschwind, Axel Bonzheim, Irina Eigentler, Thomas Amaral, Teresa Ossowski, Stephan Rieß, Olaf Flatz, Lukas Garbe, Claus Forschner, Andrea